OREX - Orexigen Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 519.51M
Enterprise Value 3120.96M
Trailing P/E N/A
Forward P/E 1-0.23
PEG Ratio (5 yr expected) 10.00
Price/Sales (ttm)0.26
Price/Book (mrq)N/A
Enterprise Value/Revenue 31.61
Enterprise Value/EBITDA 6-0.81

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin -192.65%
Operating Margin (ttm)-209.79%

Management Effectiveness

Return on Assets (ttm)-36.59%
Return on Equity (ttm)-1,635.58%

Income Statement

Revenue (ttm)75.29M
Revenue Per Share (ttm)5.01
Quarterly Revenue Growth (yoy)170.00%
Gross Profit (ttm)25.71M
EBITDA -149.63M
Net Income Avi to Common (ttm)-145.04M
Diluted EPS (ttm)-9.66
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)70.57M
Total Cash Per Share (mrq)4.25
Total Debt (mrq)171.6M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.00
Book Value Per Share (mrq)-4.00

Cash Flow Statement

Operating Cash Flow (ttm)-140.04M
Levered Free Cash Flow (ttm)66.27M

Trading Information

Stock Price History

Beta 2.14
52-Week Change 3-65.52%
S&P500 52-Week Change 322.21%
52 Week High 35.70
52 Week Low 31.14
50-Day Moving Average 31.30
200-Day Moving Average 31.97

Share Statistics

Avg Vol (3 month) 3190.18k
Avg Vol (10 day) 3217.3k
Shares Outstanding 516.6M
Float 11.6M
% Held by Insiders 110.51%
% Held by Institutions 145.48%
Shares Short 31.2M
Short Ratio 36.39
Short % of Float 314.39%
Shares Short (prior month) 31.19M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/10
Last Split Date 3Jul 12, 2016